• 0
Shop Products $

ESF INSECT CELL CULTURE MED AF1L - 99-300-01

ESF INSECT CELL CULTURE MED AF 10L MEDIA - 99-300-10

ANTIBODY RB X-QKI A300-183A - A300-183A

ANTIBODY RB X-HDAC3 A300-464A - A300-464A

ANTIBODY RB X-MST12/STK34 A300-466A - A300-466A

ANTIBODY RB X-MST12/STK34 A300-468A - A300-468A

ANTIBODY RB X-BCL11B TRIAL A300-385A-T - A300-385A-T

ANTIBODY RB X-MST1/STK4 A300-465A - A300-465A

ANTIBODY RB X-BCL11B A300-385A - A300-385A

ANTIBODY RB X-MST2/STK3 A300-467A - A300-467A

PPACK II TFA SALT-10MG - 520219-10MG

C3d, Human. Liquid. In PBS, pH 7.2. C3d is formed by the limited digestion of iC3b by trypsin or elastin. The C3d region of C3 contains the portion of the native C3 molecule which is capable of forming a covalent bond attachment to target surfaces under attack by complement.

C1q, Human. Liquid. In 135 mM NaCl, 15 mM sodium phosphate, 40% glycerol, pH 7.2. Glycoprotein composed of 18 polypeptide chains consisting of three nonidentical subunits, A, B, and C, of M.W. 29,000, 26,000 and 19,000, respectively. Present in normal human serum at 70 mg/ml.

C2, Human. Liquid. In 135 mM NaCl, 15 mM sodium phosphate, pH 6.0. Single chain glycoprotein present in normal human serum at concentration of 20 mg/ml. Classical pathway activation results in assembly of the C1,C4b complex on target surfaces.

Cyclin-Dependent Protein Kinase Inhibitor Set. Set contains 5mg of olomoucine (80053-496), 1mg of iso-olomoucine (80053-498), and 1mg of roscovitine (80054-314). Supplied with an informational sheet.

Caspase Inhibitor Set I. Set contains one 1mg sample of each of the following: Caspase-3 Inhibitor II, Z-DEVD-FMK (80051-378), Caspase-1 Inhibitor I, Ac-YVAD-CHO (80052-266), and Caspase-1 Inhibitor V, Z-VAD-FMK (80054-792). Supplied with an informational insert.

Factor P, Human. (Properdin). Liquid. In 135 mM NaCl, 15 mM sodium phosphate, pH 7.2. Glycoprotein found in circulating blood plasma in dimeric, trimeric and tetrameric forms with M.W. of 92 kDa, 138 kDa and 184 kDa, respectively. Present in normal human serum at about 20 mg/ml.

Granzyme B Inhibitor I. (Z-AAD-CMK; Z-Ala-Ala-Asp-CH2Cl). Inhibits the human and murine serine protease granzyme B, found in the cytoplasmic granules of cytotoxic T lymphocytes and natural killer cells. Purity: =95% by HPLC. Soluble in DMSO.FW: 441.9. Off-white solid, 1mg.

HUMAN IGG2 MYELOMA 2 MG - 400122-2MG

Human IgG, Fc Fragment, Plasma. 5 mg. Immunoglobulins are glycoproteins found in serum and tissue fluids of all mammals. These immunoglobulins are analyzed for purity, and prepared from serum or plasma that has been certified to be negative for HBsAg, HCV and HIV antibodies.

Caged Ins(1,4,5)P3, Trisodium. ( [D-myo-Inositol 1,4,5-trisphosphate, P4(5)-1-(2-nitrophenyl)ethyl ester, sodium]). Off-white solid. PROTECT FROM LIGHT. PROTECT FROM MOISTURE. Photolabile derivative of Ins(1,4,5)P3 that is not biologically active and is not metabolized by endogenous phosphatase.

MAP Kinase Inhibitor Set. PROTECT FROM LIGHT. Contains 5 mg of the MEK inhibitor PD 98059 (Cat. No. 513000), 1 mg each of the MAP kinase inhibitors SB 202190 (Cat. No. 559388) and SB 203580 (Cat. No. 559389) and 1 mg of the negative control, SB 202474 (Cat. No. 559387).

MEK Inhibitor Set. 1 set. Contains 5 mg of PD 98059 (VWR #80053-604), 1 mg of U0126 (VWR # 80054-912), and 1 mg of the negative control U0124 (VWR #80054-914). Packaged under inert gas. Protect from light.

NADP, Monosodium. (b-Nicotinamide-adenine dinucleotide phosphate; TPN; Co II, sodium). Off-white solid. A coenzyme that is widely distributed in living matter, participating in aerobic and anaerobic oxidations. Purity: 92% by enzymatic assay; 95% by UV. Soluble in H2O.

1-Oleoyl-2-acetyl-sn-glycerol. (OAG). Neat oil. Cell-permeable diacylglycerol analog that activates Ca2+-dependent protein kinase C. Also a stimulator of secretion and aggregation in blood platelets. Purity: 95% by TLC. Soluble in DMSO. CAS 86390-77-4, M.W. 398.6. Note: 1 set = 10 x 500 mg.

Plasmin, Human Plasma. (Fibrinolysin). Liquid. In 100 mM sodium phosphate, 1.0 mM e-aminocaproic acid, 25% glycerol, pH 7.3. Catalyzes the hydrolysis of peptides, arginine and lysine esters and converts fibrin into soluble products. Specific activity: 5 units/mg protein.

Protease Inhibitor Set. HYGROSCOPIC. Contains 50 mg of AEBSF, HCl (Cat. No. 101500), 1 mg of E-64 (Cat. No. 324890), 1 mg of EST (E-64d; Cat. No. 330005), 5 mg of Leupeptin, Hemisulfate (Cat. No. 108975), 5 mg of Pepstatin A (Cat. No. 516482), 50 mg of TLCK (Cat. No.

Proteasome Inhibitor Set. Set contains 1mg of Protesome Inhibitor I (80053-874, -876), 200-g of Lactacystin (80052-806), and 1mg of MG-132 (80053-194, -196). Supplied with an informational insert.

Protein Kinase C Inhibitor Set. Contains 250 mg of Bisindolylmaleimide I, 50 mg of Calphostin C, Cladosporium cladosporioides, 5 mg of Chelerythrine Chloride, 500 mg of G+ 6976, 500 mg of Myristoylated Protein Kinase C Inhibitor 20-28, Cell-Permeable, and 500 mg of Ro-32-0432.

Ru360. 500ug (mu)[(HCO2)(NH3)4Ru]2OCl3. Red-brown solid. Cell-permeable oxygen-bridged dinuclear ruthenium amine complex shown to bind mitochondria with high affinity. Specifically blocks Ca2+ uptake into mitochondria in-vitro & in-situ in intact myocytes. Purity:=97% capillary electrophoresis.

Thrombospondin, Human Platelets. Solid lyophilized from 600 mM NaCl, 20 mM Tris-HCl, 1 mM CaCl2, 20% sucrose, pH 7.8. Adhesive glycoprotein released in response to platelet activation by a-thrombin. Inhibits FGF-induced neovascularization of the rat cornea. An inducer of platelet aggregation.

Ouabain, Octahydrate. (Strophanthin G). Off-white solid. PROTECT FROM LIGHT. Inhibits Na+ and K+-dependent ATPases. Has cardiotonic properties. Purity: = 97% by TLC. Soluble in H2O. RTECS RN3850000, CAS 11018-89-6, M.W. 728.8. WARNING! Toxic. LD50 of = 50 mg/kg.

CALPAIN I HUMAN ERYTH 500 UG - 208713-500UG

Complement, Rabbit Serum. Lyophilized. Tested for suitability for HLA-ABC serology. Total lympholytic complement activity determined under conditions of NIH two-step cytotoxicity test that uses defined HLA isoantisera. Activity present at a titer of at least 1:4.

Phosphodiesterase Inhibitor Set. (PDE inhibitor set). Contains 10 mg of 8-Methoxymethyl-3-isobutyl-1-methylxanthine (Cat. No. 454202), a Ca2+/CaM-dependent PDE (PDE I) inhibitor; 1 mg of 4-{[3'' ,4'' -(Methylene-dioxy)benzyl]amino\}-6-methoxyquinazoline (Cat. No.

CASPASE-3 HUMAN RECO 5000 U - 235417-5000U

L(-)Sorbose. 1kg. Sorbose. White solid. Purity: =98% by HPLC. RTECS WG3195025, CAS 87-79-6.

Ru360. 1set(10 x 100 mg) (mu)[(HCO2)(NH3)4Ru]2OCl3. Reddish brown solid. Cell-permeable oxygen-bridged dinuclear ruthenium amine complex shown to bind mitochondria w/ high affinity. Specifically blocks Ca2+ uptake into mitochondria in intact myocytes. Purity:=97% capillary electrophoresis.

Phosphatase Inhibitor Cocktail Set I . 1set. In DMSO, Cocktail of three inhibitors that inhibit alkaline phosphatases as well as serine/threonine protein phosphatases. Each vial contains 2.5 mM (-)-p-Bromotetramisole Oxalate, 500 mM Cantharidin, and 500 nM Microcystin-LR. Note: 1 set = 5 x 1 ml.

Phosphatase Inhibitor Cocktail Set II. 1set. In H2O, Cocktail of five phosphatase inhibitors for the inhibition of acid and alkaline phosphatases and PTPs. Each vial contains 200mM Imidazole, 100mM Na Fluoride, 115mM Na Molybdate, 100mM Na Orthovanadate & 400mM Na Tartrate Dihydrate. 1set =5x1 ml.

p-Aminophenylmercuric Acetate. 1set. APMA. Yellow solid. Organomercurial agent used for activation of latent MMPs in vitro. Acts by facilitating loss of enzyme propeptide domain through an autolytic cleavage known as cysteine switch. RTECS OV5550000, CAS 6283-24-5. 1 set = 5 x 700 mg.

2-DEOXY-D-GALACTOSE(1.24798)1G - 259580-1GM

CARBOXYMETHYLCELLULOSE NA SAL - 217274-250GM, 250 g

CASPASE INHIBITOR SET III-1SET - 218806-1SET

D(+)Cellobiose. 25gm. Glc(beta)1,4Glc. 4-O-(beta)-D-Glucopyranosyl-D-glucose. White solid. Substrate for beta-glucosidase. Purity: =98% by HPLC. CAS 528-50-7.

MAP KINASE MOUSE RECOMB E - 454850-2000U

Maltotriose. 5GM. Glc(alpha)1,4Glc(alpha)1,4Glc. White solid. A substrate for amylomaltase. Purity: =97% by HPLC. Contaminants: glucose: =0.2% by HPLC; maltose: =0.6% by HPLC. CAS 1109-28-0.

Protease Inhibitor Cocktail Set IV. 1set. In DMSO. Four protease inhibitors specificity for inhibition of aspartic-, cysteine-, metallo-, & serine-proteases. For fungal and yeast cell extracts. 100mM AEBSF HCl, 1.5mM E-64, 2mM Pepstatin A & 500mM 1,10-Phenanthroline per vial. 1set = 5x1ml

S-Nitrosoglutathione. 1set. GSNO. SNOG. Light pink solid. Utility carrier of nitric oxide. Breaks down to produce nitric oxide at physiological pH. Causes smooth muscle relaxation and inhibits platelet aggregation. Purity:=95% by HPLC. RTECS MC0558000, CAS 57564-91-7. Note 1set = 5x2.5 mg.

FAS LIGAND PLUS(TM) RECOMBINAN - PF092-5UG

Calpain Inhibitor Set. Contains 5 mg of ALLN (VWR No. 80055-570), 25 mg of Calpain Inhibitor III (VWR No. 80055-992), 5 mg of Calpeptin (VWR No. 80010-328), 1 mg of EST (VWR No. 80051-552), and 5 mg of PD 150606 (VWR No. 80053-606). Supplied with an informational insert.

MAP Kinase Inhibitor Set II. Set includes; 5 mg of PD 98059 (VWR No. 80053-604), 1 mg each of SB 203580 (VWR No. 80054-376), and U0126 (VWR No. 80054-912), and 1 mg of the negative control, SB 202474 (VWR No. 80054-372). Supplied with an informational insert.

MMP Inhibitor III. 1mg. Off-white solid. Homophenylalamine-hydroxamic acid based broad-spectrum MMP inhibitor of MMP-1 (IC50 = 7.4 nM), MMP-2 (IC50 = 2.3 nM), MMP-3 (IC50 = 135 nM), MMP-7 (IC50 = 10 - 100 nM), and MMP-13 (IC50 = 1 - 10 nM). Purity: =90% by HPLC. Soluble in DMSO. MW 363.5.

Proteasome Inhibitor Set II. Set includes; 5 mg of ALLN (VWR No. 80055-570), 100 mg each of Epoxomicin (VWR No. 80109-094), and clasto-Lactacystin b-Lactone (VWR No. 80052-808). Protect from light. Packaged under inert gas. Supplied with an informational insert.

N Acetyllactosamine. 20mg. Galb1,4GlcNAc. O-b-D-Galactopyranosyl-b1,4-2-acetamido-2-deoxy-D-glucose. LacNAc. Solid. A substrate for galactosidases, fucosyltransferases, and sialyltransferases. Useful as a lectin inhibitory sugar. Purity: single spot by TLC. CAS 32181-59-2. MW 383.4.

XESTOSPONGIN C XESTOSPONGIA S - 682160-10UG

Y-27632. 1mg. (R)-(+)-trans-N-(4-Pyridyl)-4-(1-aminoethyl)-cyclohexanecarboxamide, 2HCl. ROCK Inhibitor. Lyophilized solid. Protect from light. Packaged under inert gas. Potent, cell-permeable & selective inhibitor of Rho-associated protein kinases. Purity: =95% by HPLC. CAS 146986-50-7. MW 338.3

ATP-G-S SOLUTION TETRALITHIU - 119123-100UL

Capsazepine. 10mg. N-[2-(4-Chlorophenyl)ethyl]-1,3,4,5-tetrahydro-7,8-dihydroxy-2H-2-benzazepine-2-carbothioamide. Off-white solid. Competitive antagonist of Capsaicin and resiniferatoxin. Purity: =98% by TLC. CAS 138977-28-3. Soluble in DMSO or MeOH. MW 376.9.

Glyburide. 1gm. Glybenclamide. White solid. Sulfonylurea that selectively blocks ATP-sensitive K+ channels. Reduced K+ conductance causes membrane depolarization & influx of Ca2+ thru voltage sensitive Ca2+ channels. Purity:=98% TLC. RTECS YS4725200, CAS 10238-21-8.

JNK Inhibitor II. 5mg. Anthra[1,9-cd]pyrazol-6(2H)-one. 1,9-pyrazoloanthrone. SAPK Inhibitor II. Orangish-solid. Cell-permeable, reversible inhibitor of c-Jun N-terminal kinase (JNK). 300x greater selectivity for JNK compared to ERK1 & p38-2 MAP kinases. Purity:=98% HPLC. CAS 129-56-6

BCL-2 C-TERMINAL TRUNCATED H - PF126-50UG

GALANTHAMINE HBR-20MG - 345670-20MG

Troglitazone. 5mg. Yellow solid. An a-tocopherol (vitamin E) moiety containing thiazolidinedione class of insulin-sensitizeracting as activator of peroxisome proliferator-activated receptors gamma (PPARg). Anti-proliferative & anti-inflammatory. Purity=98%TLC. CAS 97322-87-7. MW 441.5

Protease Inhibitor Cocktail Set V, EDTA-Free, Calbiochem® - 539137-10VL, 10 vl, Protease Inhibitor Cocktail Set V, EDTA-Free. Protease inhibitor cocktail set V, EDTA-free

Human Recombinant Insulin, Zinc - 407709-50MG, 50 mg

LOVASTATIN SODIUM SALT-5MG - 438186-5MG

SIMVASTATIN SODIUM SALT 5MG - 567021-5MG

Pepstatin A - 516481-5MG, 5 mg

IKK INHIB II WEDELOLACTONE 1MG - 401474-1MG

BAX-INHIBITING PEPTIDE 5MG - 196810-5MG

HyQ Serum-Free Media. Protein-free media with L-Glutamine designed to support growth of human embryonic kidney cell line 293 (HEK 293). Contains no animal-derived components. With Pluronic F-68, w/o phenol red. Dry powdered media. 1L in PETE bottle.

HyCloneâ„¢ Liquid Tissue Culture Media, GE Healthcare Cell Culture. HyCloneâ„¢ Liquid Tissue Culture Media, HyClone products (Cytiva) - SH30526.01, 500 mL. 500 ml, Ham's F12: with L-glutamine, Kaighn's modification

WATER CELL CULT GR ENDOTOXIN FREE 100ML - SH30529.01, 100 ml

WATER CELL CULT GR ENDOTOXIN FREE 500ML - SH30529.02, 500 ml

Water. Cell Culture Grade. 1000mL.

D-PBS 1X W/O CAL MAG 100ML - SH30028.01

HyCloneâ„¢ Hanks' Balanced Salt Solutions, HyClone products (Cytiva) - SH30031.01, 100 mL, Hank's Balanced Salt Solution (HBSS), 1X, without calcium, magnesium and with phenol red

WATER WFI QUALITY BPC 20L.

HyCloneâ„¢ CDM4CHO with L-glutamine Liquid Media, GE Healthcare Cell Culture. HyCloneâ„¢ CDM4CHO with L-glutamine Liquid Media, HyClone products (Cytiva) - SH30557.02, 1 L, CDM4CHO with L-glutamine (liquid)

HyCloneâ„¢ CDM4CHO with L-glutamine Liquid Media, GE Healthcare Cell Culture. HyCloneâ„¢ CDM4CHO with L-glutamine Liquid Media, HyClone products (Cytiva) - SH30558.02

HyCloneâ„¢ Serum-Free Media, GE Healthcare Cell Culture. HyCloneâ„¢ Serum-Free Media, HyClone products (Cytiva) - SH30548.02, 1 L, SFM4CHOâ„¢ with Sodium Bicarbonate, without L-Glutamine and Phenol Red

HyCloneâ„¢ Serum-Free Media, GE Healthcare Cell Culture. HyCloneâ„¢ Serum-Free Media, HyClone products (Cytiva) - SH30549.02, 1 L, SFM4CHOâ„¢ with L-Glutamine and Sodium Bicarbonate, without Phenol Red

HyCloneâ„¢ HyQ-RS Reduced Serum Media, HyClone products (Cytiva) - SH30564.01, 500 mL, MEM-RS liquid medium with L-glutamine, EBSS

HyQ Tissue Culture Media, Liquid Salts. DPBS Modified (1X): without Calcium, without Magnesium. Produced in accordance with FDA guidelines. Supplied in unbreakable, square PETG bottle. Volume: 500mL.

Hank'S Solution W/O P 1000Ml.

H2O WFI QUALITY 10L EA0.

HyCloneâ„¢ Classical Liquid Media: RPMI 1640, GE Healthcare Cell Culture. HyCloneâ„¢ Classical Liquid Media: RPMI 1640, HyClone products (Cytiva) - SH30605.01, 500 mL. 500 ml, RPMI 1640, without Glutamine and without Phenol red

HyCloneâ„¢ Classical Liquid Media: Leibovitz L-15, GE Healthcare Cell Culture. HyCloneâ„¢ Classical Liquid Media: Leibovitz L-15, HyClone products (Cytiva) - SH30525.01, 500 mL. 500 ml, With 2.05mM L-Glutamine

HyCloneâ„¢ Hanks' Balanced Salt Solutions, HyClone products (Cytiva) - SH30588.01, 500 mL, Hank's Balanced Salt Solution (HBSS), 1X, without calcium, magnesium, phenol red

HyCloneâ„¢ Classical Liquid Media, McCoy's 5A, GE Healthcare Cell Culture. HyCloneâ„¢ Classical Liquid Media, McCoy's 5A, HyClone products (Cytiva) - SH30200.01, 500 mL. 500 ml, With L-Glutamine

G-INTERFERON HUMAN RECOMB - 407306-100UG

RECOVERY MEDIUM, 96 MLS. Recovery medium for cloning cells (8 x 12ml).

Sfm4Insect . With L-Glutamine; 1000 Ml

Minimum Essential Medium Eagle. With out, l-glutamine and sodium bicarbonate.

Balanced Salts. With out calcium, magnesium, phenol red and sodium bicarbonate 5 liters.

Balanced Salts. With out calcium, magnesium, phenol red and sodium bicarbonate 20 liters.

Nutrient Mixture F12 Ham w/ L-Glutamine, w/o Phenol red and Sodium bicarbonate.

Nutrient Mixture F12 Ham w/ L-Glutamine, w/o Phenol red and Sodium bicarbonate.

Clearvue Mountant, Cs2, J-Med Dev-I-Leb-864.4010.

Category